DexCom earnings beat by $0.03, revenue topped estimates
Director Heather Tookes of Cra International (NASDAQ:CRAI), sold 88 shares of common stock on July 24, 2025, at a price of $177.03, for a total value of $15578. The transaction comes as the $1.19 billion market cap consulting firm trades near its 52-week high of $214.01, with InvestingPro analysis indicating the stock is currently overvalued.
Following the transaction, Tookes directly owns 3051 shares of Cra International. The sale was executed under a Rule 10b5-1 trading plan adopted on March 14, 2025. With the company’s next earnings report due on July 31, 2025, InvestingPro subscribers can access 7 additional key insights and a comprehensive Pro Research Report to better understand CRAI’s financial health, which currently rates as GOOD.
In other recent news, Charles River Associates reported strong financial results for the first quarter of 2025, surpassing analysts’ expectations. The company’s earnings per share (EPS) reached $2.22, outpacing the projected $1.95. Revenue also exceeded estimates, coming in at $181.9 million compared to the anticipated $177.13 million. Additionally, Charles River Associates announced the appointment of Dr. Gene Tien as Vice President in its Transfer Pricing Practice, bringing expertise in intercompany pricing and economic valuation issues. The firm also appointed Graham Ross as Vice President and Global Chief Marketing Officer, who will operate from the Toronto office. Ross brings over two decades of experience in professional services marketing, including roles at Borden Ladner Gervais LLP and Torys LLP. These developments reflect Charles River Associates’ ongoing efforts to strengthen its leadership team and operational capabilities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.